These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4642464)

  • 1. Further studies with propranolol in psychotic patients. Relation to initial psychiatric state, urinary catecholamines and 3-methoxy-4-hydroxyphenylglycol excretion.
    Atsmon A; Blum I; Steiner M; Latz A; Wijsenbeek H
    Psychopharmacologia; 1972; 27(3):249-54. PubMed ID: 4642464
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of acute schizophrenic psychosis with beta-adrenergic blocking agents (author's transl)].
    Rackensperger W; Gaupp R; Mattke DJ; Schwarz D; Stutte KH
    Arch Psychiatr Nervenkr (1970); 1974 Jun; 219(1):29-36. PubMed ID: 4152285
    [No Abstract]   [Full Text] [Related]  

  • 3. [Schizophrenia-like psychosis following administration of propranol].
    Koehler K; Guth W
    MMW Munch Med Wochenschr; 1977 Apr; 119(13):443-4. PubMed ID: 404537
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute organic brain syndrome with propranolol.
    Voltolina EJ; Thompson SI; Tisue J
    Clin Toxicol; 1971 Sep; 4(3):357-9. PubMed ID: 5164157
    [No Abstract]   [Full Text] [Related]  

  • 5. [Urinary excretion of catecholamines and 3-methoxy-4 hydroxy-mandelic acid in chronic schizophrenic patients undergoing Triperidol treatment].
    Masiak M; Zawiślak H
    Psychiatr Pol; 1973; 7(6):637-43. PubMed ID: 4773051
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute brain syndrome after propranolol treatment.
    Topliss D; Bond R
    Lancet; 1977 Nov; 2(8048):1133-4. PubMed ID: 73042
    [No Abstract]   [Full Text] [Related]  

  • 7. 3-Methoxy-4-hydroxyphenylglycol excretion in acutely schizophrenic patients during a controlled clinical trial of the isomers of flupenthixol.
    Joseph MH; Baker HF; Johnstone EC; Crow TJ
    Psychopharmacology (Berl); 1979 Jun; 64(1):35-40. PubMed ID: 113829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dose-response study of propranolol in chronic schizophrenics.
    Gardos G; Cole JO; Volicer L; Orzack MH; Oliff AC
    Curr Ther Res Clin Exp; 1973 Jun; 15(6):314-23. PubMed ID: 4145858
    [No Abstract]   [Full Text] [Related]  

  • 9. Propranolol in the control of schizophrenic symptoms.
    Yorkston NJ; Zaki SA; Malik MK; Morrison RC; Havard CW
    Br Med J; 1974 Dec; 4(5945):633-5. PubMed ID: 4441828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propranolol withdrawal in psychosis.
    Rosenthal S; Ellison J
    Am J Psychiatry; 1990 Apr; 147(4):534-5. PubMed ID: 2316745
    [No Abstract]   [Full Text] [Related]  

  • 11. The short-term effects of adrenergic-blocking agents in a small group of psychotic patients. Preliminary clinical observations.
    Atsmon A; Blum I; Wijsenbeek H; Maoz B; Steiner M; Ziegelman G
    Psychiatr Neurol Neurochir; 1970; 74(3):251-8. PubMed ID: 4397229
    [No Abstract]   [Full Text] [Related]  

  • 12. Psychoses associated with propranolol withdrawal.
    Golden RN; Hoffman J; Falk D; Provenzale D; Curtis TE
    Biol Psychiatry; 1989 Feb; 25(3):351-4. PubMed ID: 2914157
    [No Abstract]   [Full Text] [Related]  

  • 13. Psychosis with ordinary doses of propranolol.
    Gershon ES; Goldstein RE; Moss AJ; van Kammen DP
    Ann Intern Med; 1979 Jun; 90(6):938-9. PubMed ID: 375795
    [No Abstract]   [Full Text] [Related]  

  • 14. Urinary excretion of catecholamines and their metabolites in chronic schizophrenics treated with oxypertine and chlorpromazine.
    Kiriike N; Uete T; Motomura K; Enomoto M; Murata K
    Biol Psychiatry; 1984 Mar; 19(3):417-22. PubMed ID: 6144330
    [No Abstract]   [Full Text] [Related]  

  • 15. Propranolol-induced psychosis.
    McGahan DJ; Wojslaw A; Prasad V; Blankenship S
    Drug Intell Clin Pharm; 1984; 18(7-8):601-3. PubMed ID: 6745087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary MHPG and ward behavior in unmedicated psychiatric patients.
    Mueser KT; Rosen AJ; Dysken MW; Javaid JI
    Psychiatry Res; 1983 Dec; 10(4):275-83. PubMed ID: 6583716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary 3-methoxy-4-hydroxyphenylglycol in affective and schizophrenic patients. Behavior and symptom correlates.
    Mueser KT; Rosen AJ; Javaid JI; Davis JM
    Neuropsychobiology; 1986; 15(2):57-61. PubMed ID: 3093916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of acute and long-term beta-adrenoceptor blockade with propranolol on haemodynamics, plasma catecholamines and renin in essential hypertension.
    van Baak MA; Kho TL; Thijssen H; Rahn KH
    Eur J Clin Pharmacol; 1982; 23(5):377-82. PubMed ID: 6759143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propranolol in chronic schizophrenia: a controlled study in neuroleptic-treated patients.
    Lindström LH; Persson E
    Br J Psychiatry; 1980 Aug; 137():126-30. PubMed ID: 6107136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case report of toxic psychosis with low-dose propranolol therapy.
    Remick RA; O'Kane J; Sparling TG
    Am J Psychiatry; 1981 Jun; 138(6):850-1. PubMed ID: 7246824
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.